Xponance Inc. Decreases Stock Holdings in Azenta, Inc. (NASDAQ:AZTA)

Xponance Inc. trimmed its position in Azenta, Inc. (NASDAQ:AZTA) by 13.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,028 shares of the company’s stock after selling 945 shares during the quarter. Xponance Inc.’s holdings in Azenta were worth $317,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently made changes to their positions in AZTA. Kayne Anderson Rudnick Investment Management LLC increased its position in Azenta by 1.9% during the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 5,298,040 shares of the company’s stock valued at $278,783,000 after purchasing an additional 100,826 shares during the period. Dimensional Fund Advisors LP increased its position in Azenta by 16.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 2,970,964 shares of the company’s stock valued at $156,331,000 after purchasing an additional 421,719 shares during the period. Allspring Global Investments Holdings LLC increased its position in Azenta by 5.3% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 1,115,816 shares of the company’s stock valued at $58,714,000 after purchasing an additional 56,387 shares during the period. Schroder Investment Management Group increased its position in Azenta by 14.6% during the 4th quarter. Schroder Investment Management Group now owns 625,515 shares of the company’s stock valued at $40,746,000 after purchasing an additional 79,913 shares during the period. Finally, Bank of New York Mellon Corp increased its position in Azenta by 3.8% during the 2nd quarter. Bank of New York Mellon Corp now owns 515,393 shares of the company’s stock valued at $27,120,000 after purchasing an additional 18,680 shares during the period. 99.08% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of brokerages have issued reports on AZTA. Evercore ISI reduced their price objective on shares of Azenta from $53.00 to $50.00 and set an “in-line” rating on the stock in a research report on Tuesday. Needham & Company LLC reaffirmed a “buy” rating and issued a $69.00 target price on shares of Azenta in a research report on Wednesday, August 7th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, Azenta has an average rating of “Hold” and an average price target of $66.40.

Azenta Price Performance

NASDAQ:AZTA opened at $47.50 on Wednesday. The firm’s 50-day moving average price is $51.37 and its 200-day moving average price is $53.11. The company has a market capitalization of $2.56 billion, a PE ratio of -17.53 and a beta of 1.47. Azenta, Inc. has a 1-year low of $44.00 and a 1-year high of $69.16.

Azenta (NASDAQ:AZTA) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $0.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.07 by $0.09. The company had revenue of $173.00 million for the quarter, compared to analysts’ expectations of $166.14 million. Azenta had a negative net margin of 23.66% and a positive return on equity of 0.89%. Azenta’s revenue was up 4.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.13 EPS. Equities analysts anticipate that Azenta, Inc. will post 0.33 EPS for the current fiscal year.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.